Unknown

Dataset Information

0

HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs.

ABSTRACT: Most cases of breast cancer (BrCa) mortality are due to vascular metastasis. BrCa cells must intravasate through endothelial cells (ECs) to enter a blood vessel in the primary tumor and then adhere to ECs and extravasate at the metastatic site. In this study we demonstrate that inhibition of hypoxia-inducible factor (HIF) activity in BrCa cells by RNA interference or digoxin treatment inhibits primary tumor growth and also inhibits the metastasis of BrCa cells to the lungs by blocking the expression of angiopoietin-like 4 (ANGPTL4) and L1 cell adhesion molecule (L1CAM). ANGPTL4 is a secreted factor that inhibits EC-EC interaction, whereas L1CAM increases the adherence of BrCa cells to ECs. Interference with HIF, ANGPTL4 or L1CAM expression inhibits vascular metastasis of BrCa cells to the lungs.

SUBMITTER: Zhang H 

PROVIDER: S-EPMC3223555 | biostudies-literature | 2012 Apr

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

HIF-1-dependent expression of angiopoietin-like 4 and L1CAM mediates vascular metastasis of hypoxic breast cancer cells to the lungs.

Zhang H H   Wong C C L CC   Wei H H   Gilkes D M DM   Korangath P P   Chaturvedi P P   Schito L L   Chen J J   Krishnamachary B B   Winnard P T PT   Raman V V   Zhen L L   Mitzner W A WA   Sukumar S S   Semenza G L GL  

Oncogene 20110822 14

Most cases of breast cancer (BrCa) mortality are due to vascular metastasis. BrCa cells must intravasate through endothelial cells (ECs) to enter a blood vessel in the primary tumor and then adhere to ECs and extravasate at the metastatic site. In this study we demonstrate that inhibition of hypoxia-inducible factor (HIF) activity in BrCa cells by RNA interference or digoxin treatment inhibits primary tumor growth and also inhibits the metastasis of BrCa cells to the lungs by blocking the expres  ...[more]

Similar Datasets

Unknown Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4.
| S-EPMC3767527 | biostudies-literature
Unknown ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis.
| S-EPMC5919820 | biostudies-literature
Unknown Targeting vascular pericytes in hypoxic tumors increases lung metastasis via angiopoietin-2.
| S-EPMC4342328 | biostudies-literature
Unknown The endothelial transcription factor ERG mediates Angiopoietin-1-dependent control of Notch signalling and vascular stability.
| S-EPMC5508205 | biostudies-literature
Unknown A SUMOylation-dependent HIF-1?/CLDN6 negative feedback mitigates hypoxia-induced breast cancer metastasis.
| S-EPMC7038627 | biostudies-literature
Unknown CD146-HIF-1α hypoxic reprogramming drives vascular remodeling and pulmonary arterial hypertension.
| S-EPMC6686016 | biostudies-literature
Unknown ?-arrestin1 mediates metastatic growth of breast cancer cells by facilitating HIF-1-dependent VEGF expression.
| S-EPMC3179824 | biostudies-literature
Unknown Hypoxia-inducible factor-dependent ADAM12 expression mediates breast cancer invasion and metastasis.
| S-EPMC8126789 | biostudies-literature
Unknown Molecular mechanisms mediating metastasis of hypoxic breast cancer cells.
| S-EPMC3449282 | biostudies-literature
Unknown TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4.
| S-EPMC2390892 | biostudies-literature